Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Biomedical Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 2049-9434 Online ISSN: 2049-9442
Journal Cover
November-2024 Volume 21 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2024 Volume 21 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article Open Access

Human TDP43 is required for ALS‑related annexin A11 toxicity in Drosophila

  • Authors:
    • Jodi Barnard
    • Rachel Hunt
    • Mert Yucel
    • David Mazaud
    • Bradley N. Smith
    • Manolis Fanto
  • View Affiliations / Copyright

    Affiliations: Department of Basic and Clinical Neuroscience, Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 9NU, UK
    Copyright: © Barnard et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 165
    |
    Published online on: September 3, 2024
       https://doi.org/10.3892/br.2024.1853
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Genomics allows identification of genes and mutations associated with amyotrophic lateral sclerosis (ALS). Mutations in annexin A11 (ANXA11) are responsible for ~1% of all familial ALS and fronto‑temporal dementia cases. The present study used the fruit fly, Drosophila melanogaster, to assess the mechanism of toxicity of ANXA11 mutants in residues that are conserved in the fly ANXB11 protein, the closest homolog to human ANXA11. In immune fluorescence, lifespan and negative geotaxis assays ANXA11 mutants, while displaying some degree of alteration in localization and function, did not exert any relevant organism toxicity in Drosophila. However, they showed a specific interaction with human TAR DNA‑binding protein (TDP43). The present study illustrated that the ANXA11 mutants interact with human TDP43, but not the fly TAR DNA‑binding protein‑43 homolog (TBPH) or other ALS‑associated genes such as super oxide dismutase 1, to shorten lifespan and increase negative geotaxis defects. This sheds light both on the mechanisms underlying ALS, further elucidating the intricate molecular network implicated in ALS and placing ANXA11 as a key player in its pathology, and on the complexity of using Drosophila as a model organism for researching genes in ALS.
View Figures

Figure 1

Figure 2

Figure 3

View References

1 

Casterton RL, Hunt RJ and Fanto M: Pathomechanism heterogeneity in the amyotrophic lateral sclerosis and frontotemporal dementia disease spectrum: Providing focus through the lens of autophagy. J Mol Biol. 432:2692–2713. 2020.PubMed/NCBI View Article : Google Scholar

2 

Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, Burrell JR and Zoing MC: Amyotrophic lateral sclerosis. Lancet. 377:942–955. 2011.PubMed/NCBI View Article : Google Scholar

3 

Mejzini R, Flynn LL, Pitout IL, Fletcher S, Wilton SD and Akkari PA: ALS genetics, mechanisms, and therapeutics: Where are we now? Front Neurosci. 13(1310)2019.PubMed/NCBI View Article : Google Scholar

4 

Suzuki N, Nishiyama A, Warita H and Aoki M: Genetics of amyotrophic lateral sclerosis: Seeking therapeutic targets in the era of gene therapy. J Hum Genet. 68:131–152. 2023.PubMed/NCBI View Article : Google Scholar

5 

Smith BN, Topp SD, Fallini C, Shibata H, Chen HJ, Troakes C, King A, Ticozzi N, Kenna KP, Soragia-Gkazi A, et al: Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis. Sci Transl Med. 9(eaad9157)2017.PubMed/NCBI View Article : Google Scholar

6 

Jiang Q, Lin J, Wei Q, Li C, Hou Y, Cao B, Zhang L, Ou R, Liu K, Yang T, et al: Genetic analysis of and clinical characteristics associated with ANXA11 variants in a Chinese cohort with amyotrophic lateral sclerosis. Neurobiol Dis. 175(105907)2022.PubMed/NCBI View Article : Google Scholar

7 

Johari M, Papadimas G, Papadopoulos C, Xirou S, Kanavaki A, Chrysanthou-Piterou M, Rusanen S, Savarese M, Hackman P and Udd B: Adult-onset dominant muscular dystrophy in Greek families caused by Annexin A11. Ann Clin Transl Neurol. 9:1660–1667. 2022.PubMed/NCBI View Article : Google Scholar

8 

Liu X, Wu C, He J, Zhang N and Fan D: Two rare variants of the ANXA11 gene identified in Chinese patients with amyotrophic lateral sclerosis. Neurobiol Aging. 74:235 e9–235 e12. 2019.PubMed/NCBI View Article : Google Scholar

9 

Nagy ZF, Pal M, Salamon A, Kafui Esi Zodanu G, Füstös D, Klivényi P and Széll M: Re-analysis of the Hungarian amyotrophic lateral sclerosis population and evaluation of novel ALS genetic risk variants. Neurobiol Aging. 116:1–11. 2022.PubMed/NCBI View Article : Google Scholar

10 

Nahm M, Lim SM, Kim YE, Park J, Noh MY, Lee S, Roh JE, Hwang SM, Park CK, Kim YH, et al: ANXA11 mutations in ALS cause dysregulation of calcium homeostasis and stress granule dynamics. Sci Transl Med. 12(eaax3993)2020.PubMed/NCBI View Article : Google Scholar

11 

Nel M, Mahungu AC, Monnakgotla N, Botha GR, Mulder NJ, Wu G, Rampersaud E, van Blitterswijk M, Wuu J, Cooley A, et al: Revealing the mutational spectrum in Southern Africans with amyotrophic lateral sclerosis. Neurol Genet. 8(e654)2022.PubMed/NCBI View Article : Google Scholar

12 

Sainouchi M, Hatano Y, Tada M, Ishihara T, Ando S, Kato T, Tokunaga J, Ito G, Miyahara H, Toyoshima Y, et al: A novel splicing variant of ANXA11 in a patient with amyotrophic lateral sclerosis: Histologic and biochemical features. Acta Neuropathol Commun. 9(106)2021.PubMed/NCBI View Article : Google Scholar

13 

Teyssou E, Muratet F, Amador MD, Ferrien M, Lautrette G, Machat S, Boillée S, Larmonier T, Saker S, Leguern E, et al: Genetic screening of ANXA11 revealed novel mutations linked to amyotrophic lateral sclerosis. Neurobiol Aging. 99:102 e11–102 e20. 2021.PubMed/NCBI View Article : Google Scholar

14 

Wang Y, Duan X, Zhou X, Wang R, Zhang X, Cao Z, Wang X, Zhou Z, Sun Y and Peng D: ANXA11 mutations are associated with amyotrophic lateral sclerosis-frontotemporal dementia. Front Neurol. 13(886887)2022.PubMed/NCBI View Article : Google Scholar

15 

Yang X, Sun X, Liu Q, Liu L, Li J, Cai Z, Zhang K, Liu S, He D, Shen D, et al: Mutation spectrum of chinese amyotrophic lateral sclerosis patients with frontotemporal dementia. Orphanet J Rare Dis. 17(404)2022.PubMed/NCBI View Article : Google Scholar

16 

Zhang K, Liu Q, Liu K, Shen D, Tai H, Shu S, Ding Q, Fu H, Liu S, Wang Z, et al: ANXA11 mutations prevail in Chinese ALS patients with and without cognitive dementia. Neurol Genet. 4(e237)2018.PubMed/NCBI View Article : Google Scholar

17 

Natera-de Benito D, Olival J, Garcia-Cabau C, Jou C, Roldan M, Codina A, Expósito-Escudero J, Batlle C, Carrera-García L, Ortez C, et al: Common pathophysiology for ANXA11 disorders caused by aspartate 40 variants. Ann Clin Transl Neurol. 10:408–425. 2023.PubMed/NCBI View Article : Google Scholar

18 

Leoni TB, Gonzalez-Salazar C, Rezende TJR, Hernández ALC, Mattos AHB, Coimbra Neto AR, da Graça FF, Gonçalves JPN, Martinez ARM, Taniguti L, et al: A novel multisystem proteinopathy caused by a missense ANXA11 Variant. Ann Neurol. 90:239–252. 2021.PubMed/NCBI View Article : Google Scholar

19 

Kim EJ, Moon SY, Kim HJ, Jung NY, Lee SM and Kim YE: Semantic variant primary progressive aphasia with a pathogenic variant p.Asp40Gly in the ANXA11 gene. Eur J Neurol. 29:3124–3126. 2022.PubMed/NCBI View Article : Google Scholar

20 

Fernandopulle M, Wang G, Nixon-Abell J, Qamar S, Balaji V, Morihara R and St George-Hyslop PH: Inherited and sporadic amyotrophic lateral sclerosis and fronto-temporal lobar degenerations arising from pathological condensates of phase separating proteins. Hum Mol Genet. 28 (R2):R187–R196. 2019.PubMed/NCBI View Article : Google Scholar

21 

Liao YC, Fernandopulle MS, Wang G, Choi H, Hao L, Drerup CM, Patel R, Qamar S, Nixon-Abell J, Shen Y, et al: RNA granules hitchhike on lysosomes for long-distance transport, using annexin A11 as a molecular tether. Cell. 179:147–164 e20. 2019.PubMed/NCBI View Article : Google Scholar

22 

Sung W, Nahm M, Lim SM, Noh MY, Lee S, Hwang SM, Kim YH, Park J, Oh KW, Ki CS, et al: Clinical and genetic characteristics of amyotrophic lateral sclerosis patients with ANXA11 variants. Brain Commun. 4(fcac299)2022.PubMed/NCBI View Article : Google Scholar

23 

Casci I and Pandey UB: A fruitful endeavor: Modeling ALS in the fruit fly. Brain Res. 1607:47–74. 2015.PubMed/NCBI View Article : Google Scholar

24 

Sreedharan J, Neukomm LJ, Brown RH Jr and Freeman MR: Age-Dependent TDP43-mediated motor neuron degeneration requires GSK3, hat-trick, and xmas-2. Curr Biol. 25:2130–2136. 2015.PubMed/NCBI View Article : Google Scholar

25 

Watson MR, Lagow RD, Xu K, Zhang B and Bonini NM: A Drosophila model for amyotrophic lateral sclerosis reveals motor neuron damage by human SOD1. J Biol Chem. 283:24972–24981. 2008.PubMed/NCBI View Article : Google Scholar

26 

Romano G, Klima R, Buratti E, Verstreken P, Baralle FE and Feiguin F: Chronological requirements of TDP43 function in synaptic organization and locomotive control. Neurobiol Dis. 71:95–109. 2014.PubMed/NCBI View Article : Google Scholar

27 

Mazaud D, Kottler B, Goncalves-Pimentel C, Proelss S, Tüchler N, Deneubourg C, Yuasa Y, Diebold C, Jungbluth H, Lai EC, et al: Transcriptional Regulation of the Glutamate/GABA/Glutamine Cycle in adult glia controls motor activity and seizures in Drosophila. J Neurosci. 39:5269–5283. 2019.PubMed/NCBI View Article : Google Scholar

28 

Marchica V, Biasetti L, Barnard J, Li S, Nikolaou N, Frosch MP, Lucente DE, Eldaief M, King A, Fanto M, et al: Annexin A11 mutations are associated with nuclear envelope dysfunction in vivo and in human tissue. Brain: Jul 11, 2024 (Epub ahead of print). doi: 10.1093/brain/awae226.

29 

Baron O, Boudi A, Dias C, Schilling M, Nölle A, Vizcay-Barrena G, Rattray I, Jungbluth H, Scheper W, Fleck RA, et al: Stall in canonical autophagy-lysosome pathways prompts nucleophagy-based nuclear breakdown in neurodegeneration. Curr Biol. 27:3626–3642.e6. 2017.PubMed/NCBI View Article : Google Scholar

30 

Wang A, Conicella AE, Schmidt HB, Martin EW, Rhoads SN, Reeb AN, Nourse A, Ramirez Montero D, Ryan VH, Rohatgi R, et al: A single N-terminal phosphomimic disrupts TDP43 polymerization, phase separation, and RNA splicing. EMBO J. 37(e97452)2018.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Barnard J, Hunt R, Yucel M, Mazaud D, Smith BN and Fanto M: Human TDP43 is required for ALS‑related annexin A11 toxicity in <em>Drosophila</em>. Biomed Rep 21: 165, 2024.
APA
Barnard, J., Hunt, R., Yucel, M., Mazaud, D., Smith, B.N., & Fanto, M. (2024). Human TDP43 is required for ALS‑related annexin A11 toxicity in <em>Drosophila</em>. Biomedical Reports, 21, 165. https://doi.org/10.3892/br.2024.1853
MLA
Barnard, J., Hunt, R., Yucel, M., Mazaud, D., Smith, B. N., Fanto, M."Human TDP43 is required for ALS‑related annexin A11 toxicity in <em>Drosophila</em>". Biomedical Reports 21.5 (2024): 165.
Chicago
Barnard, J., Hunt, R., Yucel, M., Mazaud, D., Smith, B. N., Fanto, M."Human TDP43 is required for ALS‑related annexin A11 toxicity in <em>Drosophila</em>". Biomedical Reports 21, no. 5 (2024): 165. https://doi.org/10.3892/br.2024.1853
Copy and paste a formatted citation
x
Spandidos Publications style
Barnard J, Hunt R, Yucel M, Mazaud D, Smith BN and Fanto M: Human TDP43 is required for ALS‑related annexin A11 toxicity in <em>Drosophila</em>. Biomed Rep 21: 165, 2024.
APA
Barnard, J., Hunt, R., Yucel, M., Mazaud, D., Smith, B.N., & Fanto, M. (2024). Human TDP43 is required for ALS‑related annexin A11 toxicity in <em>Drosophila</em>. Biomedical Reports, 21, 165. https://doi.org/10.3892/br.2024.1853
MLA
Barnard, J., Hunt, R., Yucel, M., Mazaud, D., Smith, B. N., Fanto, M."Human TDP43 is required for ALS‑related annexin A11 toxicity in <em>Drosophila</em>". Biomedical Reports 21.5 (2024): 165.
Chicago
Barnard, J., Hunt, R., Yucel, M., Mazaud, D., Smith, B. N., Fanto, M."Human TDP43 is required for ALS‑related annexin A11 toxicity in <em>Drosophila</em>". Biomedical Reports 21, no. 5 (2024): 165. https://doi.org/10.3892/br.2024.1853
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team